M. Ben-Hassel

713 total citations
11 papers, 407 citations indexed

About

M. Ben-Hassel is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, M. Ben-Hassel has authored 11 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 6 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Biology. Recurrent topics in M. Ben-Hassel's work include Glioma Diagnosis and Treatment (8 papers), Brain Metastases and Treatment (5 papers) and Meningioma and schwannoma management (2 papers). M. Ben-Hassel is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), Brain Metastases and Treatment (5 papers) and Meningioma and schwannoma management (2 papers). M. Ben-Hassel collaborates with scholars based in France and Switzerland. M. Ben-Hassel's co-authors include Y Guégan, Abderrahmane Hamlat, Stéphan Saïkali, C. Carrié, Claire Alapetite, D Gedouin, J.F. Laurent, S. Chapet, Jean Philippe Maire and V. Bernier and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

M. Ben-Hassel

10 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Ben-Hassel France 8 287 165 121 94 66 11 407
Yutaka Sawamura Japan 8 371 1.3× 253 1.5× 171 1.4× 145 1.5× 113 1.7× 21 511
John C. Van Gilder United States 9 211 0.7× 134 0.8× 136 1.1× 78 0.8× 94 1.4× 11 455
R. del Carpio Canada 8 244 0.9× 124 0.8× 114 0.9× 147 1.6× 73 1.1× 13 485
Robert DaRosso United States 8 302 1.1× 173 1.0× 113 0.9× 170 1.8× 45 0.7× 8 450
Maryanne H. Marymont United States 18 418 1.5× 100 0.6× 230 1.9× 202 2.1× 287 4.3× 38 738
Hong W. Chin United States 12 375 1.3× 56 0.3× 235 1.9× 148 1.6× 144 2.2× 23 562
Bernadine Donahue United States 12 507 1.8× 127 0.8× 249 2.1× 239 2.5× 178 2.7× 19 635
Abby Hollander United States 11 133 0.5× 80 0.5× 120 1.0× 78 0.8× 60 0.9× 18 425
Phillip Littman United States 8 375 1.3× 95 0.6× 124 1.0× 200 2.1× 60 0.9× 9 525
Joseph M. Kim United States 15 359 1.3× 112 0.7× 273 2.3× 93 1.0× 166 2.5× 20 660

Countries citing papers authored by M. Ben-Hassel

Since Specialization
Citations

This map shows the geographic impact of M. Ben-Hassel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Ben-Hassel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Ben-Hassel more than expected).

Fields of papers citing papers by M. Ben-Hassel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Ben-Hassel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Ben-Hassel. The network helps show where M. Ben-Hassel may publish in the future.

Co-authorship network of co-authors of M. Ben-Hassel

This figure shows the co-authorship network connecting the top 25 collaborators of M. Ben-Hassel. A scholar is included among the top collaborators of M. Ben-Hassel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Ben-Hassel. M. Ben-Hassel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Alapetite, Claire, Hervé J. Brisse, Catherine Patte, et al.. (2010). Pattern of relapse and outcome of non-metastatic germinoma patients treated with chemotherapy and limited field radiation: the SFOP experience. Neuro-Oncology. 12(12). 1318–25. 104 indexed citations
2.
Carrié, C., Jacques Grill, Dominique Figarella‐Branger, et al.. (2009). Online Quality Control, Hyperfractionated Radiotherapy Alone and Reduced Boost Volume for Standard Risk Medulloblastoma: Long-Term Results of MSFOP 98. Journal of Clinical Oncology. 27(11). 1879–1883. 49 indexed citations
3.
Hamlat, Abderrahmane, et al.. (2007). Cerebellar pleomorphic xanthoastrocytoma: case report and literature review. Surgical Neurology. 68(1). 89–94. 29 indexed citations
4.
Hamlat, Abderrahmane, Stéphan Saïkali, J Chaperon, et al.. (2006). Proposal of a scoring scale as a survival predictor in intracranial oligodendrogliomas. Journal of Neuro-Oncology. 79(2). 159–168. 6 indexed citations
5.
Hamlat, Abderrahmane, Stéphan Saïkali, J Chaperon, et al.. (2005). Oligodendroglioma: clinical study and survival analysis correlated with chromosomal anomalies. Neurosurgical FOCUS. 19(5). 1–9. 11 indexed citations
6.
Hamlat, Abderrahmane, Stéphan Saïkali, J.F. Laurent, et al.. (2005). Malignant Transformation of Intra-Cranial Epithelial Cysts: Systematic Article Review. Journal of Neuro-Oncology. 74(2). 187–194. 75 indexed citations
8.
Carrié, C., S. Hoffstetter, J.L. Habrand, et al.. (1998). Impact of targeting deviations on outcome in medulloblastoma. Update of the french medulloblastoma study group (French society of pediatric oncology). International Journal of Radiation Oncology*Biology*Physics. 42(1). 184–184. 3 indexed citations
9.
Ben-Hassel, M., et al.. (1992). Unusual combination of Cis platinum and radiotherapy followed by a three fractions per day irradiation in splitcourse: a phase I-II study in brain glioma patients.. PubMed. 168(9). 502–12. 1 indexed citations
10.
Guégan, Y, et al.. (1989). [Surgical lesions of the brain stem].. PubMed. 35 Suppl 1. 1–133. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026